Los Angeles Capital Management
ASMB icon

Los Angeles Capital Management’s Assembly Biosciences ASMB Stock Holding History

Los Angeles Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,155
Closed -$64K – 1532
2021
Q1 		$64K Sell
1,155
-1,203
-51% -$79.7K ﹤0.01% 1571
2020
Q4 		$171K Buy
2,358
+356
+18% +$41.8K ﹤0.01% 1484
2020
Q3 		$395K Buy
+2,002
New +$504K ﹤0.01% 1176
2020
Q2 		– Sell
-1,088
Closed -$194K – 1453
2020
Q1 		$194K Buy
+1,088
New +$233K ﹤0.01% 1182

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Los Angeles Capital Management's ASMB Position: Q2 2021 in Review

Los Angeles Capital Management sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 1,155 shares — an estimated $64K sold.

Los Angeles Capital Management first reported a position in ASMB in Q1 2020 and held it in 4 quarters. The position peaked at $395K in Q3 2020. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • Los Angeles Capital Management reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 1,155 Assembly Biosciences shares in Q2 2021, an estimated $64K.
  • Los Angeles Capital Management first reported a position in Assembly Biosciences in Q1 2020 and held it in 4 quarters.
  • Los Angeles Capital Management's Assembly Biosciences position peaked at $395K in Q3 2020.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on Los Angeles Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.